Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin plus panitumumab in KRAS-mutant metastatic colorectal cancer
2009-014452-30Phase 2Active
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2009
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panitumumab and simvastatin in colorectal cancer (CRC), sponsored by Leiden University Medical Center. Primary endpoint: Progression-free and alive at 11 weeks. Started Oct 2009; status: active.
02
Drugs
panitumumabsimvastatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2009-014452-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014452-30.